CNBX Pharmaceuticals Inc. (CNBX) Net Equity Issued and Repurchased (2014 - 2024)
CNBX Pharmaceuticals' (CNBX) quarterly Net Equity Issued and Repurchased came in at $30000.0 in Q4 2024, up 20.03% YoY from $24993.0 in Q4 2023, and up 20.03% on a QoQ basis from $24993.0 in Q4 2023.
CNBX Pharmaceuticals Inc. (CNBX) Net Equity Issued and Repurchased (2014 - 2024) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 8 years of Net Equity Issued and Repurchased data on file, last reported at $30000.0 in Q4 2024.
- Quarterly Net Equity Issued and Repurchased rose 20.03% year-over-year to $30000.0 in Q4 2024, while the trailing twelve-month figure through Nov 2024 was $54993.0 (up 120.03% YoY) and the FY2019 annual result came in at $7.3 million, up 370.6% from the prior year.
- Net Equity Issued and Repurchased grew to $30000.0 in Q4 2024, from $24993.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $30000.0 in Q4 2024 to a low of $24993.0 in Q4 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2024 | 30,000.00 |
| Nov 30, 2024 | 30,000.00 |
| Nov 30, 2023 | 24,993.00 |
| Nov 30, 2023 | 24,993.00 |
| Aug 31, 2019 | -7.00 |
| Aug 31, 2019 | -7.00 |
| Feb 28, 2019 | 67,466.00 |
| Feb 28, 2019 | 67,466.00 |
| Nov 30, 2018 | 7.23 Mn |
| Nov 30, 2018 | 7.23 Mn |
| Aug 31, 2018 | 500,000.00 |
| Aug 31, 2018 | 500,000.00 |
| Feb 28, 2018 | 1.05 Mn |
| Feb 28, 2018 | 1.05 Mn |
| Aug 31, 2017 | 555,553.00 |
| Aug 31, 2017 | 555,553.00 |
| May 31, 2017 | 3.02 Mn |
| May 31, 2017 | 3.02 Mn |
| Feb 28, 2017 | 458,500.00 |
| Feb 28, 2017 | 458,500.00 |